🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 34 of 114

  1. FKB238 (bevacizumab)

    Centus Biotherapeutics Europe Limited

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    1 trial

  2. FLECAINIDE

    Pari Pharma GmbH

    Patent Foramen Ovale Closure Atrial Arrhytmia or Tachycardia

    phase 3 small molecule active

    1 trial

  3. FLORTAUCIPIR (18F), FLORTAUCIPIR (18F), FLORBETAPIR (18F), FLORBETAPIR (18F)

    The George Institute

    Semantic Variant Primary Progressive Aphasia, Alcohol Use Disorder, Organic amnesia syndrome, Narcolepsy, Alzheimer, Lewy Body Dementia

    phase 3 small molecule active

    1 trial

  4. FLUCONAZOLE , SULFAMETHOXAZOLE AND TRIMETHOPRIM , AMOXICILLIN , METRONIDAZOLE , CIPROFLOXACIN , AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , CLINDAMYCIN , DOXYCYCLINE , LINEZOLID , SODIUM CHLORIDE SOLUTION 0.9%

    The George Institute

    Patients with hip or knee infections

    phase 3 small molecule active

    1 trial

  5. FLUDARABINE PHOSPHATE, DAUNORUBICIN HYDROCHLORIDE, BUSULFAN, Azacitidine Accord 25 mg/mL powder for suspension for injection, CYTARABINE, THIOTEPA

    Fondazione Telethon ETS

    Higher-risk-myelodysplastic syndromes

    phase 3 small molecule active

    1 trial

  6. FLUOROURACIL , CAPECITABINE , Folikabi 10 mg/ml oplossing voor injectie/infusie, OXALIPLATIN

    Disc Medicine

    Rectal cancer

    phase 3 small molecule active

    1 trial

  7. FLUOROURACIL , OXALIPLATIN , GEMCITABINE , FOLIC ACID

    Pari Pharma GmbH

    Pancreatic adenocarcinoma (PAC)

    phase 3 small molecule active

    1 trial

  8. FLUOROURACIL, BEVACIZUMAB, FOLINIC ACID, OXALIPLATIN, ivonescimab

    Summit Therapeutics

    Metastatic colorectal cancer

    phase 3 small molecule active

    1 trial

  9. FLUOROURACIL, CAPECITABINE, Zimberelimab, OXALIPLATIN, FLUOROURACIL, CALCIUM FOLINATE, DOMVANALIMAB, NIVOLUMAB, FLUOROURACIL, CAPECITABINE

    Arcus Biosciences

    Metastatic Esophageal or Gastric Cancer, Esophageal or Gastric Cancer

    phase 3 small molecule active

    1 trial

  10. FLUOROURACIL, CISPLATIN, CAPECITABINE, CISPLATIN, TRASTUZUMAB, Placebo for Pembrolizumab, OXALIPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion, CAPECITABINE, TRASTUZUMAB

    Merck Sharp and Dohme

    Gastric or gastroesophageal junction (GEJ) adenocarcinoma

    phase 3 small molecule active

    1 trial

  11. FLUOROURACIL, DOCETAXEL, OPDIVO 10 mg/mL concentrate for solution for infusion., OXALIPLATIN, CALCIUM LEVOFOLINATE, CISPLATIN, DOXORUBICIN HYDROCHLORIDE

    Verona Pharma Ireland Limited

    Gastric adenocarcinoma with peritoneal metastases

    phase 3 small molecule active

    1 trial

  12. FLUOROURACIL, Tecentriq 1 200 mg concentrate for solution for infusion, CALCIUM FOLINATE PENTAHYDRATE, OXALIPLATIN

    The George Institute

    stage III colon adenocarcinoma with deficient MMR

    phase 3 small molecule active

    1 trial

  13. FLUTICASONE , Dupilumab, SALBUTAMOL , BUDESONIDE , MONTELUKAST , Matched placebo for test (dupilumab low dose), Matched placebo for test (dupilumab high dose), BECLOMETASONE , Dupilumab, SALMETEROL AND FLUTICASONE

    Sanofi-aventis Healthcare Pty Ltd

    Respiratory tract diseases - Wheezing, Asthma

    phase 3 small molecule active

    1 trial

  14. FMX-101, 4% minocycline foam

    VYNE Therapeutics

    Acne Vulgaris

    phase 3 small molecule completed

    2 trials

  15. FMX101

    Cutia Therapeutics (Shanghai) Co., Ltd

    Acne Vulgaris

    phase 3 small molecule completed

    1 trial

  16. FMX101

    VYNE Therapeutics

    Acne Vulgaris

    phase 3 small molecule completed

    1 trial

  17. FMX103 1.5%

    VYNE Therapeutics

    Papulopustular Rosacea

    phase 3 small molecule completed

    1 trial

  18. FMX103 minocycline foam 1.5%

    VYNE Therapeutics

    Facial Papulopustular Rosacea

    phase 3 small molecule completed

    2 trials

  19. FOSFOMYCIN , SULFAMETHOXAZOLE AND TRIMETHOPRIM

    Tour Hekla

    Benign Prostate Hyperplasia

    phase 3 small molecule active

    1 trial

  20. FS MDPI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    2 trials

  21. FST-201 (dexamethasone 0.1%) Otic Suspension

    Takeda

    Acute Otitis Externa

    phase 3 small molecule terminated

    1 trial

  22. FST-201 (dexamethasone 0.1%) Otic Suspension

    Takeda

    Acute Fungal Otitis Externa

    phase 3 small molecule terminated

    1 trial

  23. FST201 (dexamethasone 0.1% with povidone-iodine 1%)

    Takeda

    Acute Otitis Externa

    phase 3 small molecule completed

    1 trial

  24. FULVESTRANT , EXEMESTANE , ABEMACICLIB

    Eli Lilly Co.

    Breast Cancer

    phase 3 small molecule active

    1 trial

  25. FUROSEMIDE , DULOXETINE

    Ningbo Cancer Hospital

    ER positive HER2 negative breast cancer stages I-II

    phase 3 small molecule active

    1 trial

  26. FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, HYDROCHLOROTHIAZIDE

    The George Institute

    Acute Heart Failure

    phase 3 small molecule active

    1 trial

  27. FX006

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    2 trials

  28. FX006

    Pacira Ireland Limited

    Osteoarthritis, Hip

    phase 3 small molecule terminated

    1 trial

  29. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 3 small molecule completed

    1 trial

  30. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    4 trials

  31. Fabrazyme 35 mg powder for concentrate for solution for infusion, venglustat GZ402671 - SAR402671, Replagal 1 mg/ml concentrate for solution for infusion., Replagal 1 mg/ml concentrate for solution for infusion., Galafold 123 mg hard capsules, Replagal 1 mg/ml concentrate for solution for infusion.

    Sanofi-aventis Healthcare Pty Ltd

    Fabry’s disease

    phase 3 small molecule active

    1 trial

  32. Faceptor

    Biotech Pharmaceutical Co.,

    Breast Cancer Metastatic

    phase 3 small molecule completed

    2 trials

  33. Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)

    Takeda

    Hemophilia A or B With Inhibitors

    phase 3 mab completed

    1 trial

  34. Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)

    Baxalta Innovations GmbH

    Hemophilia A or B With Inhibitors

    phase 3 mab completed

    1 trial

  35. Faricimab

    Hoffmann-La Roche

    Diabetic Macular Edema

    phase 3 small molecule completed

    1 trial

  36. Farletuzumab

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 3 small molecule terminated

    1 trial

  37. Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes

    Lxo Ireland Designated Activity Company

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  38. Fasedienol Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder (SAD)

    phase 3 small molecule active

    1 trial

  39. Fasedienol Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder

    phase 3 small molecule active

    1 trial

  40. Fasiglifam (TAK-875)

    Takeda

    Glycemic Control

    phase 3 small molecule terminated

    1 trial

  41. Fasiglifam (TAK-875)

    Takeda

    Diabetes Mellitus, Type 2

    phase 3 small molecule terminated

    1 trial

  42. Fasinumab

    Regeneron UK Limited

    Osteoarthritis of the Knee or Hip

    phase 3 small molecule completed

    1 trial

  43. Fasinumab

    Regeneron UK Limited

    Low Back Pain

    phase 3 small molecule completed

    1 trial

  44. Fasinumab

    Regeneron UK Limited

    Osteoarthritis, Knee

    phase 3 small molecule completed

    4 trials

  45. Fasinumab

    Regeneron UK Limited

    Chronic Low Back Pain

    phase 3 small molecule terminated

    1 trial

  46. Faster-acting insulin aspart

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    1 trial

  47. Fazirsiran Injection

    Takeda

    Alpha1-Antitrypsin Deficiency

    phase 3 small molecule active

    3 trials

  48. Febuxostat

    Takeda

    Cardiovascular Disease

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.